HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metabotropic glutamate receptor 5 antagonism with fenobam: examination of analgesic tolerance and side effect profile in mice.

AbstractBACKGROUND:
The metabotropic glutamate receptor 5 noncompetitive antagonist fenobam is analgesic in rodents. Future development of fenobam as an analgesic in humans will require a favorable long-term treatment profile and a lack of significant deleterious side effects. This study aimed to determine whether tolerance to fenobam's analgesic effects developed over 14 days and to assess for side effects in mice.
METHODS:
Mouse models of pain, locomotor behavior, and coordination were used. Fenobam or vehicle (n = 8 or 11 per group) was administered for 14 days, and analgesic tolerance to fenobam was assessed using the formalin test. Histopathologic examination, hematology, and clinical chemistry analysis after 14-day fenobam administration were also assessed (n = 12 or 9). The effects of fenobam on locomotor activity were assessed in the open field and elevated zero maze (n = 8 or 7). Coordination was assessed using ledge crossing and vertical pole descent tasks (n = 11 or 10).
RESULTS:
Tolerance to fenobam's analgesic effect did not develop after 14 days. Chronic fenobam administration resulted in statistically significantly less weight gain compared with vehicle control subjects, but did not cause any physiologically or statistically significant hematologic abnormalities, altered organ function, or abnormal histopathology of the liver, brain, or testes. Fenobam administration resulted in a metabotropic glutamate receptor 5-dependent increase in exploratory behavior but does not impair motor coordination at analgesic doses.
CONCLUSIONS:
Analgesic tolerance to repeat fenobam dosing does not develop. Chronic dosing of up to 14 days is well tolerated. Fenobam represents a promising candidate for the treatment of human pain conditions.
AuthorsMichael C Montana, Beth A Conrardy, Laura F Cavallone, Benedict J Kolber, Lesley K Rao, Suellen C Greco, Robert W Gereau 4th
JournalAnesthesiology (Anesthesiology) Vol. 115 Issue 6 Pg. 1239-50 (Dec 2011) ISSN: 1528-1175 [Electronic] United States
PMID22037639 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Analgesics
  • Imidazoles
  • Receptor, Metabotropic Glutamate 5
  • Receptors, Metabotropic Glutamate
  • fenobam
Topics
  • Analgesics (blood, pharmacology)
  • Analysis of Variance
  • Animals
  • Behavior, Animal (drug effects)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drug Tolerance
  • Eating (drug effects)
  • Imidazoles (blood, pharmacology)
  • Male
  • Mice
  • Motor Activity (drug effects)
  • Pain (drug therapy)
  • Pain Measurement
  • Receptor, Metabotropic Glutamate 5
  • Receptors, Metabotropic Glutamate (antagonists & inhibitors)
  • Weight Gain (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: